GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 355 filers reported holding GLOBUS MED INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $317,760 | -16.6% | 6,400 | 0.0% | 0.36% | -12.9% |
Q2 2023 | $381,056 | +5.1% | 6,400 | 0.0% | 0.41% | +4.9% |
Q1 2023 | $362,496 | -23.7% | 6,400 | 0.0% | 0.39% | -32.7% |
Q4 2022 | $475,328 | +24.8% | 6,400 | 0.0% | 0.58% | +17.6% |
Q3 2022 | $381,000 | +6.1% | 6,400 | 0.0% | 0.49% | +6.7% |
Q2 2022 | $359,000 | -23.9% | 6,400 | 0.0% | 0.46% | +15.8% |
Q1 2022 | $472,000 | +2.2% | 6,400 | 0.0% | 0.40% | +28.2% |
Q4 2021 | $462,000 | -5.7% | 6,400 | 0.0% | 0.31% | -15.2% |
Q3 2021 | $490,000 | -1.2% | 6,400 | 0.0% | 0.37% | -5.4% |
Q2 2021 | $496,000 | +25.6% | 6,400 | 0.0% | 0.39% | +18.6% |
Q1 2021 | $395,000 | -5.3% | 6,400 | 0.0% | 0.33% | -12.5% |
Q4 2020 | $417,000 | +31.5% | 6,400 | 0.0% | 0.38% | +26.7% |
Q3 2020 | $317,000 | +3.9% | 6,400 | 0.0% | 0.30% | +8.4% |
Q2 2020 | $305,000 | +12.1% | 6,400 | 0.0% | 0.27% | -0.7% |
Q1 2020 | $272,000 | +5.0% | 6,400 | +45.5% | 0.28% | +97.8% |
Q4 2019 | $259,000 | +15.1% | 4,400 | 0.0% | 0.14% | +14.9% |
Q3 2019 | $225,000 | – | 4,400 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |